Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syndrome-Reference-Cited by-同舟云学术

Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syndrome

Published:2017-09-04 Issue:1 Volume:12 Page:
ISSN:1750-1326
Container-title:Molecular Neurodegeneration
language:en
Short-container-title:Mol Neurodegeneration

Author:

Tatebe Harutsugu,Kasai Takashi,Ohmichi Takuma,Kishi Yusuke,Kakeya Tomoshi,Waragai Masaaki,Kondo Masaki,Allsop David,Tokuda Takahiko

Funder

Japan Society for the Promotion of Science

Japan Agency for Medical Research and Development

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Clinical Neurology,Molecular Biology

Link

http://link.springer.com/content/pdf/10.1186/s13024-017-0206-8.pdf

Reference42 articles.

1. Mann DM. Cerebral amyloidosis, ageing and Alzheimer's disease; a contribution from studies on Down's syndrome. Neurobiol Aging. 1989;10:397–9.

2. Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. Lancet Neurol. 2014;13:614–29. https://doi.org/10.1016/S1474-4422(14)70090-0 .

3. Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, et al. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol. 2009;65:403–13. https://doi.org/10.1002/ana.21610 .

4. Skillbäck T, Farahmand BY, Rosén C, Mattsson N, Nägga K, Kilander L, et al. Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia. Brain. 2015;138:2716–31. https://doi.org/10.1093/brain/awv181 .

5. Blennow K, Dubois B, Fagan AM, Lewczuk P, de Leon MJ, Hampel H. Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease. Alzheimers Dement. 2015;11:58–69. https://doi.org/10.1016/j.jalz.2014.02.004 .

Cited by 208 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preparation and application of multiple particle binding-liposomes for electrochemiluminescent signal amplification in bioassays;Analytical and Bioanalytical Chemistry;2024-09-14

2. Clinical significance of plasma candidate biomarkers of Alzheimer’s Disease;Neurologia i Neurochirurgia Polska;2024-08-28

3. Alzheimer's Disease and Vascular Dementia, Connecting and Differentiating Features;Current Alzheimer Research;2024-07-29

4. A novel monoclonal antibody generated by immunization with granular tau oligomers binds to tau aggregates at 423-430 amino acid sequence;Scientific Reports;2024-07-26

5. Role of Artificial Intelligence in Cognitive Assessment and Early Detection of Alzheimer's Disease;Advances in Medical Technologies and Clinical Practice;2024-06-28